Company intelligence / Profile preview

Biomakers

Buenos Aires, Buenos Aires, Argentinabiomakers.net ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Biomakers has demonstrated the ability to deliver high-quality genomic information rapidly to personalize cancer care across Latin America. Recent collaborations have shown the utility of their platform in identifying novel biomarkers that may improve immunotherapy outcomes in NSCLC patients. They have processed thousands of samples using advanced sequencing technologies combined with AI-powered analytics.

Therapeutic areas: OncologyRare Diseases
Modalities: Molecular diagnosticsGenomic testing (multi-gene panels, whole exome sequencing)
Industry: Molecular Diagnostics

Partnerships

TOPAZIUM (AI-driven healthtech collaboration for immunotherapy biomarker discovery)

Beyond the preview

Go deeper on Biomakers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomakers.

Explore the full profile